The Procter & Gamble Company (NYSE:PG) Shares Sold by Avior Wealth Management LLC

Avior Wealth Management LLC reduced its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 1.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,187 shares of the company’s stock after selling 493 shares during the period. Avior Wealth Management LLC’s holdings in Procter & Gamble were worth $5,094,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in PG. Concurrent Investment Advisors LLC boosted its holdings in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after buying an additional 4,035 shares during the last quarter. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble in the third quarter worth approximately $5,705,000. Welch Group LLC increased its position in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after purchasing an additional 2,990 shares in the last quarter. Swiss National Bank raised its stake in Procter & Gamble by 0.6% in the 3rd quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock valued at $1,213,403,000 after purchasing an additional 39,000 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Ma. Fatima Francisco sold 96,000 shares of Procter & Gamble stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the transaction, the chief executive officer now directly owns 13,721 shares in the company, valued at approximately $2,332,570. This trade represents a 87.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the sale, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 270,727 shares of company stock valued at $46,014,037 in the last three months. 0.18% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on PG. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Piper Sandler began coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. JPMorgan Chase & Co. increased their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Finally, Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.

View Our Latest Report on PG

Procter & Gamble Price Performance

Procter & Gamble stock opened at $170.77 on Wednesday. The company’s 50 day simple moving average is $170.07 and its 200-day simple moving average is $168.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The company has a market capitalization of $402.17 billion, a price-to-earnings ratio of 29.44, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the company earned $1.83 earnings per share. The firm’s quarterly revenue was down .6% compared to the same quarter last year. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.